Inventor · disambiguated record
Stephen Paul Wargacki
Also filed as: WARGACKI STEPHEN · Wargacki Stephen Paul
9 granted patents·15 pending applications·8 citations·filing 2017–2025
80Inventor score
Top patents by PatentIndex Score
24 records- 0185US11541002B2Oral film compositions and dosage forms having precise active dissolution profilesAQUESTIVE THERAPEUTICS INC·Filed 2019·Granted Jan 3, 2023·2 cites·24 claims
- 0284US11191737B2Enhanced delivery epinephrine compositionsAQUESTIVE THERAPEUTICS INC·Filed 2017·Granted Dec 7, 2021·5 cites·28 claims
- 0379US12290597B2Oral film compositions and dosage forms having precise active dissolution profilesAQUESTIVE THERAPEUTICS INC·Filed 2022·Granted May 6, 2025·0 cites·14 claims
- 0478US12403090B2Oral film compositions and dosage forms having precise active dissolution profilesAQUESTIVE THERAPEUTICS INC·Filed 2022·Granted Sep 2, 2025·0 cites·14 claims
- 0577US11273131B2Pharmaceutical compositions with enhanced permeationAQUESTIVE THERAPEUTICS INC·Filed 2017·Granted Mar 15, 2022·1 cites·58 claims
- 0676US2025339367A1Oral film compositions and dosage forms having precise active dissolution profilesAQUESTIVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0772US12023309B2Enhanced delivery epinephrine compositionsAQUESTIVE THERAPEUTICS INC·Filed 2022·Granted Jul 2, 2024·0 cites·33 claims
- 0872US2024148673A1Enhanced delivery epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0965US2025108017A1Enhanced delivery epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1064US2022160657A1Enhanced delivery epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1163US12465564B2Oral and nasal compositions and methods of treatmentAQUESTIVE THERAPEUTICS INC·Filed 2022·Granted Nov 11, 2025·0 cites·17 claims
- 1262US2024016734A1Enhanced delivery epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1359US2023130055A1Pharmaceutical compositions with enhanced stability profilesAQUESTIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1458US2022347117A1Dosage forms having equivalent biocomparable profilesAQUESTIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2022233471A1Prodrug compositions and methods of treatmentAQUESTIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1651US12433850B2Enhanced delivery epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2018·Granted Oct 7, 2025·0 cites·39 claims
- 1749US2021128511A1Prodrug compositions and methods of treatmentAQUESTIVE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1849US2019091281A1Delivery pharmaceutical compositions including permeation enhancersAQUESTIVE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1948US12427121B2Enhanced delivery epinephrine compositionsAQUESTIVE THERAPEUTICS INC·Filed 2017·Granted Sep 30, 2025·0 cites·32 claims
- 2048US2025281392A1Topical delivery of epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2147US2019022022A1Pharmaceutical compositions with enhanced permeationAQUESTIVE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2246US2021145731A1Multimodal compositions and methods of treatmentAQUESTIVE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2344US2018125977A1Enhanced delivery epinephrine compositionsMONOSOL RX LLC·Filed 2017·Application pending·0 cites
- 2438US2017290776A1Pharmaceutical compositions with enhanced permeationMONOSOL RX LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Paul Wargacki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →